PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
20-May-2024 U.S. Biotechnology Industry is Rising Rapidly Up to USD 1,794.11 Bn by 2033 - Exclusive Report by Nova One Advisor. Precedence Research
20-May-2024 Cresset Targets Global Growth with New India HQ Cresset
17-May-2024 Alfa Chemistry Debuts Shape Memory Alloys, Nitinol SMAs, and 3D Printing Alloys Alfa Chemistry
16-May-2024 ANGLE INDEPENDENT STUDY OF OVARIAN CANCER CTCS HARVESTED BY THE PARSORTIX SYSTEM HIGHLIGHTS POTENTIAL TO PREDICT PROGRESSION FREE SURVIVAL FOR DRUG TRIALS ANGLE plc
16-May-2024 Veranova and Phorum.AI Partner to Deliver Generative AI Chemistry Optimization to the Pharmaceutical & Biotech Industry Veranova and Phorum.AI
16-May-2024 Veranova and Phorum.AI Partner to Deliver Generative AI Chemistry Optimization to the Pharmaceutical & Biotech Industry Veranova
16-May-2024 BenevolentAI announces further success with AstraZeneca collaboration as novel Heart Failure target selected BenevolentAI
16-May-2024 Transgene provides business and financial update for Q1 2024 Transgene
16-May-2024 Chiesi Group Forges Alliance with Karolinska Institutet to Tackle Urgent Health Challenges Chiesi Group
16-May-2024 Axovia Therapeutics Announces Presentation of Preclinical Data Supporting Lead Program AXV-101 for Treatment of Blindness Associated with BBS1 Mutations at ASGCT Axovia Therapeutics
16-May-2024 Newron reports compelling additional data documenting the efficacy of evenamide in pivotal study 008A in poorly responding schizophrenia patients Newron Pharmaceuticals
16-May-2024 SYMBICORT (budesonide/formoterol) TURBOHALER 200/6® ACCEPTED FOR USE IN SCOTLAND AS RELIEVER THERAPY FOR PATIENTS WITH MILD ASTHMA AGED 12 YEARS AND OLDER AstraZeneca
16-May-2024 Pharmanovia and Closed Loop Medicine launch the OptiZest study to investigate personalised dose management in hypertension Pharmanovia
15-May-2024 Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparathyroidism Treated with TransCon™ PTH (Palopegteriparatide): 2-year Results from Phase 3 PaTHway Trial Ascendis Pharma A/S
15-May-2024 HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China HUTCHMED
15-May-2024 HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui HUTCHMED
15-May-2024 Publication in Nature Immunology outlining the contribution of B cells to anticancer immunosurveillance highlights Alchemab’s capabilities and potential to develop new cancer therapies Alchemab
15-May-2024 Chiesi Group Forges Alliance with Karolinska Institutet to Tackle Urgent Health Challenges Chiesi
15-May-2024 Robocath unveils survey findings on users’ current expectations and future developments Andrew Lloyd Associates
14-May-2024 InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs InsightRX